只是保持滚动? - - 一个全面的审查,以加速疫苗产品生命周期
Janis Stiefel1, Jan Zimmer1, Jeffrey L Schloßhauer2
1Fraunhofer Institute for Microengineering and Microsystems IMM, Carl-Zeiss-Straße 18-20, 55129 Mainz, Germany.
Vaccines
|August 26, 2023
概括
快速生产疫苗对于未来的流行病至关重要. 本次审查强调了药物开发,配方和弹性制造方面的创新,以加快疫苗生命周期并克服供应挑战.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 生物技术是生物技术.
- 制药科学 制药科学
背景情况:
- 随着COVID-19的爆发,人们越来越需要快速开发和生产疫苗.
- 现有的疫苗制造工艺在速度和可扩展性方面存在局限性.
- 加快的疫苗开发突出了产能限制和改善生产的领域.
研究的目的:
- 审查最近的跨学科方法,以快速适应和生产疫苗.
- 确定加速疫苗产品生命周期的关键驱动因素.
- 为未来的流行病应对提供灵活和可扩展的疫苗制造指南.
主要方法:
- 关于技术创新的文献综述.
- 利益相关者分析.利益相关者分析.
- 价值主张帆布应用程序.
- 检查药理学,配方,验证和生产方面的问题.
主要成果:
- 确定了加速疫苗生产的四个主要驱动因素:计算机化候选人选,模块化生产,数字化质量管理和具有透明供应链的弹性商业模式.
- 突出了药理学,配方和验证阶段的创新.
- 解决了供应瓶和物流网络的问题.
结论:
- 已识别的驱动因素可以指导灵活和可扩展的疫苗生产.
- 实施这些战略可以加强对未来的流行病情况的快速反应.
- 为了优化疫苗制造,必须采用多方面的方法.
相关概念视频
Vaccinations
44.7K
Overview
44.7K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Administration and Therapy Phases: Overview
521
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
521
Pharmacovigilance
886
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
886
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K


